HMOX1 and breast carcinoma: HMOX-1 may be involved in drug resistance of breast cancer cells by preventing apoptosis and autophagy, since siRNA knockdown of HMOX-1 enhanced the cytotoxicity of doxorubicin in MDA-MB-231 and BT549 cells55, 56.